Search results

1903 results for All evidence | Scottish Medicines Consortium - SMC

Sorted by Relevance . Sort by Date

Showing results 61 to 70. View options for downloading these results.

Displaying only Scottish Medicines Consortium for your search.
Return to full search results.

  • saxagliptin (Onglyza)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    10 November 2014

    Indication: In adult patients aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control as combination therapy with insulin (with or without metformin), when this regimen...

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)
  • saxagliptin (Onglyza)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    09 December 2013

    Indication: In adult patients aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control as triple oral therapy in combination with metformin plus a sulphonylurea when this...

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)
  • saxagliptin (Onglyza)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    10 March 2014

    Indication: Monotherapy in adult patients aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control inadequately controlled by diet and exercise alone and for whom metformin...

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)
  • saxagliptin + metformin (Komboglyze)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    10 June 2013

    Indication: Adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type 2 diabetes mellitus inadequately controlled on their maximally tolerated dose...

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)
  • secukinumab (Cosentyx)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    08 June 2015

    Indication: treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)
  • saxagliptin metformin (Kombogylze)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    13 January 2014

    Indication: In combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type 2...

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)
  • secukinumab (Cosentyx)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    11 July 2016

    Indication: Treatment of active ankylosing spondylitis (AS) in adults who have responded inadequately to conventional therapy.

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)
  • secukinumab (Cosentyx)

    Source:
    Scottish Medicines Consortium - SMC (Remove filter)

    08 August 2016

    Indication: Alone or in combination with methotrexate, for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) ...

    Type:
    Guidance (Add filter)
    Type:
    Prescribing and Technical Information (Add filter)

Results per page | | |